Literature DB >> 11701072

Efficacy and quality-of-life impact of adult tonsillectomy.

N Bhattacharyya1, L J Kepnes, J Shapiro.   

Abstract

OBJECTIVE: To determine the quality-of-life impact and overall efficacy of adult tonsillectomy for chronic tonsillitis.
DESIGN: Cross-sectional survey analysis of patients at least 1 year after undergoing adult tonsillectomy. INTERVENTIONS AND OUTCOME MEASURES: The Glasgow Benefit Inventory was used to quantify the health benefit of tonsillectomy. Data were collected for demographics and antibiotic use, physician visits, and workdays missed due to chronic tonsillitis for the 12 months before and after tonsillectomy.
RESULTS: Sixty-five patients returned completed surveys. Mean age was 27.3 years, and mean follow-up was 42.6 months. The improvements in the total score (+27.1), general health subscore (+34.7), social functioning subscore subscore (+14.4), and physical functioning subscore (+9.5) of the Glasgow Benefit Inventory were each statistically significant (P<.001), indicating a significant health benefit of tonsillectomy. Statistically significant decreases in mean weeks receiving antibiotics (-7.8 weeks), mean physician visits (-5.4), and mean workdays missed (-6.3 days) were noted after tonsillectomy (P<.001).
CONCLUSIONS: Adult tonsillectomy provides a significant quality-of-life improvement for patients with chronic tonsillitis. Tonsillectomy also affords decreases in medical resource utilization and missed workdays after tonsillectomy. Such factors should be incorporated into decision making when considering tonsillectomy.

Entities:  

Mesh:

Year:  2001        PMID: 11701072     DOI: 10.1001/archotol.127.11.1347

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  17 in total

1.  [Development and validation of the Tonsillectomy Outcome Inventory 14].

Authors:  T Skevas; C Klingmann; P K Plinkert; I Baumann
Journal:  HNO       Date:  2012-09       Impact factor: 1.284

2.  Recurrent tonsillitis in adults: quality of life after tonsillectomy.

Authors:  Götz Senska; Stefanie Ellermann; Stefan Ernst; Hildegard Lax; Philipp Dost
Journal:  Dtsch Arztebl Int       Date:  2010-09-10       Impact factor: 5.594

3.  Long-Term Results From Tonsillectomy in Adults.

Authors:  Götz Senska; Halil Atay; Carolin Pütter; Philipp Dost
Journal:  Dtsch Arztebl Int       Date:  2015-12-11       Impact factor: 5.594

4.  [Outcome after tonsillectomy for chronic tonsillitis].

Authors:  I Baumann
Journal:  HNO       Date:  2005-05       Impact factor: 1.284

5.  The effect of tonsillectomy on the morbidity from recurrent tonsillitis.

Authors:  C M Douglas; K Lang; W M Whitmer; J A Wilson; K Mackenzie
Journal:  Clin Otolaryngol       Date:  2017-03-09       Impact factor: 2.597

6.  [Chronic rhinosinusitis. Subjective assessment of benefit 1 year after functional endonasal sinus surgery].

Authors:  I Baumann; G Blumenstock; C Klingmann; M Praetorius; P K Plinkert
Journal:  HNO       Date:  2007-11       Impact factor: 1.284

7.  Health-related quality of life after tonsillotomy versus tonsillectomy in young adults: 6 years postsurgery follow-up.

Authors:  Sara Wireklint; Elisabeth Ericsson
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-03-16       Impact factor: 2.503

8.  [Evidence-based medicine, health-related quality of life, and outcomes research: utility and necessity of validated survey instruments].

Authors:  T Wilhelm
Journal:  HNO       Date:  2012-09       Impact factor: 1.284

9.  Preoperative serum pattern analysis to predict the outcome of tonsillectomy in adults with chronic tonsillitis.

Authors:  Katharina Geißler; Silvia Bohne; Robert Siggel; Svea Sachse; Michael Kiehntopf; Michael Bauer; Eberhard Straube; Orlando Guntinas-Lichius
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-05-11       Impact factor: 2.503

10.  Benefit from tonsillectomy in adult patients with chronic tonsillitis.

Authors:  Ingo Baumann; Hanka Kucheida; Gunnar Blumenstock; Ilse M Zalaman; Marcus M Maassen; Peter K Plinkert
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-02-21       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.